You are here

Pfizer

Drugmakers push forward on large-scale production of coronavirus vaccines

Drugmakers push forward on large-scale production of coronavirus vaccines

BioPharma Dive

Operation Warp Speed

Moderna Therapeutics

Flag link:

Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out

Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out

Stat

Moderna Therapeutics

Flag link:

Pfizer leans into gene therapy manufacturing with 'build-buy-partner' strategy

Pfizer leans into gene therapy manufacturing with 'build-buy-partner' strategy

Fierce Pharma

Vivet Therapeutics

WIlson's disease

build-buy-partner

Flag link:

OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib

OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib

Pharmaceutical Business Review

Flag link:

ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer

ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer

Fierce Pharma

Flag link:

ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial

ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial

Fierce Pharma

head and neck cancer

clinical trials

Flag link:

Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols

Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols

Fierce Pharma

Moderna Therapeutics

clinical trials

clinical trial transparency

Flag link:

Pfizer plans DTC effort to pitch COVID-19 shot safety, joining a fall flurry of vaccine messaging

Pfizer plans DTC effort to pitch COVID-19 shot safety, joining a fall flurry of vaccine messaging

Fierce Pharma

DTC advertising

Flag link:

Pfizer tips pipeline to add $15B to sales in coming years

Pfizer tips pipeline to add $15B to sales in coming years

Fierce Biotech

drug development

Flag link:

Pfizer, BioNTech Say COVID-19 Vaccine Might Be Ready by End of October

Pfizer, BioNTech Say COVID-19 Vaccine Might Be Ready by End of October

BioSpace

Flag link:

The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause

The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause

Motley Fool

clinical trials

Flag link:

Pfizer and BioNTech announce plan to expand Covid-19 vaccine trial

Pfizer and BioNTech announce plan to expand Covid-19 vaccine trial

Stat

clinical trials

Flag link:

Pfizer's Latest Stealthy Move Could Help It Win the Coronavirus Vaccine Race

Pfizer's Latest Stealthy Move Could Help It Win the Coronavirus Vaccine Race

Motley Fool

Flag link:

Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU

Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU

Motley Fool

Flag link:

Merck’s pneumonia vaccine posts two more hits

Merck’s pneumonia vaccine posts two more hits

EP Vantage

Flag link:

COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval

COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval

Fierce Pharma

Operation Warp Speed

Moderna Therapeutics

Flag link:

Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio

Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio

Endpoints

Aspen Pharmacare

Flag link:

Big pharma spinouts grow up

Big pharma spinouts grow up

EP Vantage

Flag link:

Pfizer CEO Expects Pivotal Coronavirus Vaccine Data in October

Pfizer CEO Expects Pivotal Coronavirus Vaccine Data in October

Motley Fool

clinical trials

Flag link:

CDC sets its sights on November COVID-19 vaccine deliveries: report

CDC sets its sights on November COVID-19 vaccine deliveries: report

Fierce Pharma

Moderna Therapeutics

Flag link:

Pages